EUVIMEDEUVIMED entdecken
Crossref

Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of

Mitsuru Yanagaki, Shinji Onda, Kenei Furukawa, Tomohiko Taniai, Koichiro Haruki, Munetoshi Akaoka, Yoshihiro Shirai, Michinori Matsumoto, Takeshi Gocho, Tadashi Uwagawa, Toru Ikegami

Transplantation Proceedings · 2023

DOI: 10.1016/j.transproceed.2023.03.046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Mitsuru Yanagaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Liver Transplantation, End Stage Liver Disease, Liver Cirrhosis, Biliary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Uehara Memorial Foundation, Japan Society for the Promotion of Science, Princess Takamatsu Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although primary biliary cholangitis (PBC) is considered a good indication for living-donor liver transplantation (LDLT), the postoperative results are not well known. METHODS: At Jikei University Hospital, 14 patients with PBC underwent LDLT from February 2007 to June 2022. We consider PBC with a Model for End-Stage Liver Disease (MELD) score of 0.7 and MELD score of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationEnd Stage Liver DiseaseLiver Cirrhosis, BiliaryChildHumansFemaleMiddle AgedMaleLiving DonorsRetrospective StudiesSeverity of Illness IndexGraft SurvivalTreatment Outcome

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: k-furukawa@jikei.ac.jp.

Förderung

  • Uehara Memorial Foundation
  • Japan Society for the Promotion of Science
  • Princess Takamatsu Cancer Research Fund

Zitieren

APA

Yanagaki, M., Onda, S., Furukawa, K., Taniai, T., Haruki, K., Akaoka, M., Shirai, Y., Matsumoto, M., Gocho, T., Uwagawa, T., & Ikegami, T. (2023). Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.03.046

Vancouver

Yanagaki M, Onda S, Furukawa K, Taniai T, Haruki K, Akaoka M, et al. Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.03.046

BibTeX
@article{Yanagaki2023,
  author = {Yanagaki, Mitsuru and Onda, Shinji and Furukawa, Kenei and Taniai, Tomohiko and Haruki, Koichiro and Akaoka, Munetoshi and Shirai, Yoshihiro and Matsumoto, Michinori and Gocho, Takeshi and Uwagawa, Tadashi and Ikegami, Toru},
  title = {Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of},
  journal = {Transplantation Proceedings},
  year = {2023},
  doi = {10.1016/j.transproceed.2023.03.046}
}
Kostenlos starten →